GlassScriptPhysician profile
Stacey G Johnson
NPI 1700316270
$2,125.34
in general payments reported to CMS, 2019-2025
27 companies · $476 in 2025
The $476 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.28 · 2022: $338 · 2023: $530 · 2024: $733 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,656 · Education: $83.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,656.16 |
| Education | $83.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $389.16 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $328.61 | 2024-2025 | |
| Organon LLC | $241.24 | 2022-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $190.23 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $130.67 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $122.13 | 2022-2025 | |
| Agile Therapeutics, INC. | $75.58 | 2022-2024 | Twirla |
| Millicent US INC | $68.51 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $59.86 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $57.61 | 2022-2024 | |
| Abbvie INC. | $57.34 | 2021-2024 | |
| Medtronic, INC. | $51.82 | 2022-2023 | Truclear |
| Aspira Women'S Health INC | $42.73 | 2022 | |
| Myovant Sciences INC. | $36.69 | 2021-2022 | |
| Pfizer INC. | $30.45 | 2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $26.82 | 2022 | |
| Coopersurgical, INC. | $26.06 | 2023 | Paragard T 380a |
| Daiichi Sankyo INC. | $25.75 | 2022 | |
| Monaghan Medical Corporation | $25.35 | 2023 | Aerochamber |
| Gynesonics, INC. | $20.60 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sanara Medtech INC. | $19.76 | 2025 | Celleraterx |
| Lilly USA, LLC | $19.54 | 2024 | Zepbound |
| Dexcom, INC. | $17.25 | 2024 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $16.98 | 2024 | Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $15.64 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $14.71 | 2025 | |
| Evofem Biosciences, INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.